Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality

New Content ItemThe annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was sent to 4458 dialysis facilities at the end of 2018; among these facilities, 4402 facilities (98.7%) responded to the facility questionnaire, and 4222 (94.7%) responded to the patient questionnaire.


See this article:

Featured article: Peritoneal Dialysis Guidelines 2019 Part 1 (Position paper of Japanese Society of Dialysis Therapy)

New Content ItemApproximately 10 years have passed since the Peritoneal Dialysis Guidelines were formulated in 2009. Much evidence has been reported during the succeeding years, which were not taken into consideration in the previous guidelines, e.g., the next peritoneal dialysis PD trial of encapsulating peritoneal sclerosis (EPS) in Japan, the significance of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), the effects of icodextrin solution, new developments in peritoneal pathology, and a new international recommendation on a proposal for exit-site management.

See this article:

Featured article: Amelioration of hemodialysis-induced oxidative stress and fatigue with a hemodialysis system employing electrolyzed water containing molecular hydrogen

New Content ItemA novel hemodialysis (HD) system employing electrolyzed water containing molecular hydrogen (E-HD) has been developed to improve the bio-compatibility of HD. This study examined the impact of E-HD on changes in redox state during HD and HD-related fatigue.

See this article:


Articles

Upcoming conferences

The 32nd Annual Meeting of the Japan Society for Blood Purification Critical Care
2-3 October 2021, Rafre Saitama

The 27th Annual Meeting of the Japanese Society for Peritoneal Dialysis
30-31 October 2021, TORANOMON HILLS FORUM

The 15th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
11-12 November 2021, Pacifico Yokohama

The 24th Annual Meeting of Japan Academy of Nephrology Nursing
13-14 November, 2021, FUKUOKA CONVENTION CENTER

The 42nd Japanese Society for Pediatrics Renal Failure
9-10 December, 2021, Osaka City Central Public Hall

The 55th Annual Meeting of Japanese Society for Clinical Renal Transplantation
23-25 February 2022

The 12th Annual Meeting of the Japanese Society of Renal Rehabilitation
26-27 March 2022, Okayama Convention Center

The 67th Annual Meeting of the Japanese Society for Dialysis Therapy
30 June - 2 July 2022, Pacifico Yokohama

The 33rd Annual Meeting of the Japan Society for Blood Purification Critical Care
7-8 October 2022, Juroku Plaza

The 25th Annual Meeting of Japan Academy of Nephrology Nursing
15-16 October, 2022, Nagoya Congress Center

The 16th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
29-30 October 2022, DEJIMA MESSE NAGASAKI

The 43rd Japanese Society for Pediatrics Renal Failure    
24-25 November, 2022, Yumoto Fujiya Hotel

The 13th Annual Meeting of the Japanese Society of Renal Rehabilitation
17-19 March 2023, Omiya Sonic City Hall

The 68th Annual Meeting of the Japanese Society for Dialysis Therapy
16-18, June 2023, KCC: Kobe International Convention Center

Submit your manuscript

RRT logo

Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.

Aims and scope

Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.

RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.

Overcoming Language Barriers

english editingIf your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.

Society affiliations

Renal Replacement Therapy is the official publication of the following societies:





About the Editors

Dr. Takashi Shigematsu, Editor-in-Chief

Dr. Takashi Shigematsu is currently the emeritus professor of the department of nephrology at the Wakayama Medical University School of Medicine, Japan. He is now actively working as Director of Division of Nephrology and Clinical Research Center in Rinku General Medical Center. He is also a member of the International Society of Nephrology and the American Society of Nephrology.

His research interests focus on Mineral and Bone Disorder associated with chronic kidney disease (CKD) including vascular calcification, Senescence. Renal Anemia is another his major interest. In addition, he has been investigating and working in the fields of hemodialysis and vascular access, peritoneal dialysis, blood purification medicine in acute kidney injury, and kidney transplantation.


New Content ItemProf. Masanori Abe, Deputy Editor

Professor and Chair of the Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.

Prof. Abe also serves as the Chief Director of Blood Purification Center of Nihon University Itabashi Hospital. His professional interests include Nephrology and Renal Replacement Therapy.

Annual Journal Metrics

  • Speed
    42 days to first decision for reviewed manuscripts only
    39 days to first decision for all manuscripts
    141 days from submission to acceptance
    19 days from acceptance to publication

    Usage 
    276,989 Downloads
    13 Altmetric mentions